Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × Exanthema × Clear all

Phase

Status

Completed 7 Withdrawn 2 Unknown 2 Terminated 2 Not yet recruiting 2 Recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Breast Neoplasms 1160 Neoplasms 873 Carcinoma, Non-Small-Cell Lung 741 Prostatic Neoplasms 646 Colorectal Neoplasms 573 Lung Neoplasms 466 Leukemia, Myeloid, Acute 408 Pancreatic Neoplasms 374 Neoplasm Metastasis 365 Carcinoma, Hepatocellular 349 Ovarian Neoplasms 337 Multiple Myeloma 333 Stomach Neoplasms 326 Recurrence 310 Squamous Cell Carcinoma of Head and Neck 272 Melanoma 258 Uterine Cervical Neoplasms 250 Brain Neoplasms 230 Triple Negative Breast Neoplasms 229 Precursor Cell Lymphoblastic Leukemia-Lymphoma 228 Head and Neck Neoplasms 225 Glioblastoma 216 Lymphoma 212 Endometrial Neoplasms 208 Esophageal Neoplasms 203 Rectal Neoplasms 194 Sarcoma 184 Carcinoma, Renal Cell 178 Colonic Neoplasms 170 Lymphoma, Non-Hodgkin 169

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06399029 2025-11-19

TRUX-LST

University of Zurich

Phase 2 Recruiting

Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡